88 related articles for article (PubMed ID: 28945941)
1. RhPDCD5 combined with dexamethasone increases antitumor activity in multiple myeloma partially via inhibiting the Wnt signalling pathway.
Cheng Q; Liu L; Fu Y; Zhang Y; Yang Y; Liu J
Clin Exp Pharmacol Physiol; 2018 Feb; 45(2):140-145. PubMed ID: 28945941
[TBL] [Abstract][Full Text] [Related]
2. [Effect of human recombinant PDCD5 protein on cell apoptosis of multiple myeloma KM3 cells induced by dexamethasone and its mechanism].
Liu J; Li X; Gui R; Jiang T; Wang E
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):725-31. PubMed ID: 20693715
[TBL] [Abstract][Full Text] [Related]
3. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
Liang Y; Li X; He X; Qiu X; Jin XL; Zhao XY; Xu RZ
Eur J Haematol; 2016 Oct; 97(4):371-8. PubMed ID: 26821882
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
5. Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma.
Sriskandarajah P; De Haven Brandon A; MacLeod K; Carragher NO; Kirkin V; Kaiser M; Whittaker SR
BMC Cancer; 2020 Mar; 20(1):269. PubMed ID: 32228485
[TBL] [Abstract][Full Text] [Related]
6. Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells.
Shi L; Song Q; Zhang Y; Lou Y; Wang Y; Tian L; Zheng Y; Ma D; Ke X; Wang Y
Biochem Biophys Res Commun; 2010 May; 396(2):224-30. PubMed ID: 20398626
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway.
Wu Y; Wang H
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29205703
[TBL] [Abstract][Full Text] [Related]
8. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling.
Rao AS; Kremenevskaja N; Resch J; Brabant G
Eur J Endocrinol; 2005 Dec; 153(6):929-38. PubMed ID: 16322400
[TBL] [Abstract][Full Text] [Related]
9. [Sensitizing effect of recombinant human PDCD5 protein on chemotherapy of acute monocytic leukemia cell line U937 and its mechanism].
Wang YF; Song QS; Zhang YM; Ma DL; Wang Y; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):277-81. PubMed ID: 20416151
[TBL] [Abstract][Full Text] [Related]
10. Establishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism.
Feng W; Fu Y; Zhang Y; Lv B; Li X; Zhang F; Gui R; Liu J
Int J Clin Exp Pathol; 2015; 8(9):10635-43. PubMed ID: 26617773
[TBL] [Abstract][Full Text] [Related]
11. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
[TBL] [Abstract][Full Text] [Related]
12. Wnt9A Induction Linked to Suppression of Human Colorectal Cancer Cell Proliferation.
Ali I; Medegan B; Braun DP
Int J Mol Sci; 2016 Apr; 17(4):495. PubMed ID: 27049382
[TBL] [Abstract][Full Text] [Related]
13. Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Schmeel FC; Schmeel LC; Kim Y; Schmidt-Wolf IG
Hematol Oncol; 2014 Dec; 32(4):197-204. PubMed ID: 24470348
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human PDCD5 protein enhances chemosensitivity of breast cancer in vitro and in vivo.
Wang L; Wang C; Su B; Song Q; Zhang Y; Luo Y; Li Q; Tan W; Ma D; Wang L
Biochem Cell Biol; 2013 Dec; 91(6):526-31. PubMed ID: 24219296
[TBL] [Abstract][Full Text] [Related]
15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
16. The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
Munugalavadla V; Mariathasan S; Slaga D; Du C; Berry L; Del Rosario G; Yan Y; Boe M; Sun L; Friedman LS; Chesi M; Leif Bergsagel P; Ebens A
Oncogene; 2014 Jan; 33(3):316-25. PubMed ID: 23318440
[TBL] [Abstract][Full Text] [Related]
17. The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in
Díaz T; Rodríguez V; Lozano E; Mena MP; Calderón M; Rosiñol L; Martínez A; Tovar N; Pérez-Galán P; Bladé J; Roué G; de Larrea CF
Haematologica; 2017 Oct; 102(10):1776-1784. PubMed ID: 28751557
[TBL] [Abstract][Full Text] [Related]
18. [Effects of dexamethasone on lung morphogenesis in rats and the expression of Wnt signal transduction pathway in the lung of offspring].
Wang Q; Zhao DY
Zhonghua Er Ke Za Zhi; 2008 Apr; 46(4):286-90. PubMed ID: 19099732
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
Geng W; Guo X; Zhang L; Ma Y; Wang L; Liu Z; Ji H; Xiong Y
Biomed Pharmacother; 2018 Nov; 107():484-494. PubMed ID: 30107344
[TBL] [Abstract][Full Text] [Related]
20. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
Edwards CM; Edwards JR; Lwin ST; Esparza J; Oyajobi BO; McCluskey B; Munoz S; Grubbs B; Mundy GR
Blood; 2008 Mar; 111(5):2833-42. PubMed ID: 18094333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
